{"schema_version":"1","generated_at":"2026-10-29T22:30:07.076Z","data_as_of":null,"url":"https://www.findmykol.com/kol/craig-seaman","json_url":"https://www.findmykol.com/kol/craig-seaman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"craig-seaman","name":"Craig Seaman","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Hemophilia Center of Western Pennsylvania","institution_url":"https://www.findmykol.com/institution/hemophilia-center-of-western-pennsylvania","city":"Pittsburgh","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1366605826","orcid":"0000-0002-5134-1660","openalex":"A5055393662"},"summary":"Craig Seaman is a Hematology physician affiliated with Hemophilia Center of Western Pennsylvania. OpenAlex indexes 49 publications with 563 citations (h-index 13); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":49,"cited_by_count":563,"h_index":13,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02586012","title":"Weight-based Dosing in Hemophilia A","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Craig Seaman","source_url":"https://clinicaltrials.gov/study/NCT02586012","trial_url":"https://www.findmykol.com/trial/NCT02586012"},{"nct":"NCT02098993","title":"Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Craig Seaman","source_url":"https://clinicaltrials.gov/study/NCT02098993","trial_url":"https://www.findmykol.com/trial/NCT02098993"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":23,"shown":3,"withheld":20,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":13721.01,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1366605826"},{"payer":"Novo Nordisk Inc","program_year":2025,"amount_usd":1965,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1366605826"},{"payer":"Takeda Pharmaceuticals U.S.A., Inc.","program_year":2025,"amount_usd":1405.25,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1366605826"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1366605826","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":84.1,"classes_total":4,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":66.5,"drugs":[{"name":"Eliquis","share_pct":62.4},{"name":"Xarelto","share_pct":19.8},{"name":"Fondaparinux Sodium","share_pct":17.8}],"max_beneficiaries":null},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":10.7,"drugs":[{"name":"Warfarin Sodium","share_pct":51.3},{"name":"Jantoven","share_pct":48.7}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":12.9,"classes_total":1,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":12.9,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":3,"classes_total":1,"classes":[{"class":"Platelet Aggregation Inhibitor","setting":"prescribed","share_pct":3,"drugs":[{"name":"Aspirin-Dipyridamole Er","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":33.8,"facility_pct":66.2},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2020,"last":2024},"rows_total":5,"shown":3,"withheld":2,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K23HL148762","title":"The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study","fiscal_year":2024,"amount_usd":"171815","organization":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","source_url":"https://reporter.nih.gov/quickSearch/K23HL148762"},{"project":"K23HL148762","title":"The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study","fiscal_year":2023,"amount_usd":"171815","organization":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","source_url":"https://reporter.nih.gov/quickSearch/K23HL148762"},{"project":"K23HL148762","title":"The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study","fiscal_year":2022,"amount_usd":"165597","organization":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","source_url":"https://reporter.nih.gov/quickSearch/K23HL148762"}],"source":"grants"},"publications":{"total":47,"shown":5,"withheld":42,"matched_by":"OpenAlex author record","recent":[{"title":"Impact of Tranexamic Acid Administration on Postpartum Hemorrhage in Women with Von Willebrand Disease Receiving Recombinant VWF at Delivery: The VWD-Woman Trial","year":2025,"journal":"SSRN Electronic Journal","source_url":"https://doi.org/10.2139/ssrn.5136152","status":"verified"},{"title":"Impact of tranexamic acid on postpartum hemorrhage in type 1 von Willebrand disease treated with recombinant VWF","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025017046","status":"verified"},{"title":"Risk of postpartum hemorrhage in women with von willebrand disease by treatment type: An analysis of real-world data","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-1096","status":"verified"},{"title":"Glycoprotein 1bM Assay and Von Willebrand Disease: A Change in Diagnosis","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-211045","status":"verified"},{"title":"Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial","year":2023,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(23)00119-9","status":"verified"}],"source":"works"},"contact":{"address_1":"3636 BLVD OF THE ALLIES","city":"Pittsburgh","state":"PA","zip":"152134306","phone":"412-209-7280","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1366605826","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":20,"funding":2,"publications":42}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-10-22","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}